Aggressive new treatment strategy targets toughest multiple myeloma cases
NCT ID NCT00572169
Summary
This study tests whether an intensive treatment approach works better for people with newly diagnosed multiple myeloma, especially those with high-risk genetic features. The treatment involves high-dose chemotherapy with stem cell transplants, followed by long-term maintenance medications. Researchers want to see if this approach improves survival compared to previous treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Arkansas for Medical Sciences/Myeloma Institute
Little Rock, Arkansas, 72205, United States
Conditions
Explore the condition pages connected to this study.